Kashiv BioSciences

Research lab
Aug 11, 2026

Amneal closes $1.1B Kashiv Biosciences acquisition

The combination of Bridgewater-based Amneal Pharmaceuticals and Kashiv Biosciences from Piscataway creates a global leader in biosimilars ahead of a looming Loss of Exclusivity set to hit the market.